Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucky LtdfiledCriticalLucky Ltd
Priority to MYPI9301251priorityCriticalpatent/MY116465A/en
Publication of MY116465ApublicationCriticalpatent/MY116465A/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
PROVIDED HEREIN ARE: A MODIFIED HUMAN GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR("HGM-CSF") GENE USEFUL FOR THE MASS PRODUCTION OF HGMCSF IN YEAST, AN EXPRESSION VECTOR CONTAINING SAID GENE, A YEAST CELL TRANSFORMED WITH SAID EXPRESSION VECTOR AND A PROCESS FOR PRODUCING HGM-CSF BY EMPLOYING THE YEAST CELL. THE MODIFIED HGM-CSF GENE POSSESSES YEAST PREFERRED CODONS AND IS ABLE TO INACTIVATE TWO N-LINKED GLYCOSYLATION RECOGNITION SITES PRESENT IN NATIVE GMCSF. ( FIG 1 – A ) ( FIG 1 – B )
MYPI93012511993-06-281993-06-28Modified human granulocyte macrophage-colony stimulating factor gene and expression thereof in yeast
MY116465A
(en)